CoreAge Rx
9.8/10 publisher preferenceOur recommended provider: a $79 starting offer, a separate order total and a clinical decision that still comes first.
Read CoreAge Rx review →The review library · 61 records
A provider name is the start of the comparison.
Open its review for the offer, the evidence and the questions still worth asking.
Start with the full review
Three offers. Three separate records.
- 01
Our recommended provider
CoreAge Rx
9.8/10 publisher preferenceOur recommended provider: a $79 starting offer, a separate order total and a clinical decision that still comes first.
Starting at $79/month
Read the review → - 02
Featured provider
SuperHealthy Rx
9.6/10 publisher preferenceA $85 semaglutide campaign with included-service claims and recurring refill settings to understand.
Semaglutide $85/month; tirzepatide $135/month advertised
Read the review → - 03
Featured provider
Likeness Rx
9.4/10 publisher preferenceMonthly and prepaid GLP-1 plans: compare $79 starting language with the actual $948 annual semaglutide total.
Semaglutide from $79/month; tirzepatide from $129/month
Read the review →
61 of 61 provider records
SuperHealthy Rx
9.6/10 publisher preferenceA $85 semaglutide campaign with included-service claims and recurring refill settings to understand.
Read SuperHealthy Rx review →Likeness Rx
9.4/10 publisher preferenceMonthly and prepaid GLP-1 plans: compare $79 starting language with the actual $948 annual semaglutide total.
Read Likeness Rx review →AgelessRx
Editorial source recordAgelessRx: a current selected GLP-1 offer has not been established for this directory record. Confirm the provider’s present service scope, prescription process and complete payment before treating older descriptions as current.
Read AgelessRx review →Alloy
Editorial source recordMidlife-focused care includes both branded and compounded pathways.
Read Alloy review →Alpha
Editorial source recordAlpha’s current public page identifies a weight-loss care pathway. The selected medication, total charge and ongoing care terms still need a program-specific quote.
Read Alpha review →Amazon One Medical
Editorial source recordCash-pay visits and a pharmacy coupon are separate components of Amazon’s offer.
Read Amazon One Medical review →Amble Health
Editorial source recordAmble Health: a current selected GLP-1 offer has not been established for this directory record. Confirm the provider’s present service scope, prescription process and complete payment before treating older descriptions as current.
Read Amble Health review →Brello Health
Editorial source recordBrello Health: a current selected GLP-1 offer has not been established for this directory record. Confirm the provider’s present service scope, prescription process and complete payment before treating older descriptions as current.
Read Brello Health review →Calibrate
Editorial source recordCalibrate’s current homepage emphasizes employer-covered access. An older direct-to-consumer price should not be substituted for eligibility and costs under a current employer arrangement.
Read Calibrate review →Circle Medical
Editorial source recordCircle Medical’s public site is a primary-care platform. That general scope does not establish that a particular GLP-1 prescription or bundled medication program is available to every patient.
Read Circle Medical review →Claya
Editorial source recordClaya’s homepage uses both monthly and multi-month offer language.
Read Claya review →Clover Meds
Editorial source recordClover publishes a term ladder; the annual monthly equivalent is not the single-month price.
Read Clover Meds review →Cora Health
Editorial source recordCora names its annual charge and monthly alternative, making commitment visible.
Read Cora Health review →Doctronic
Editorial source recordAn AI conversation is distinct from the licensed doctor visit.
Read Doctronic review →Eden
Editorial source recordEden: the older record pointed to a domain that now presents workplace software. That destination is not evidence of a weight-care offer. Current Eden treatment, pharmacy and pricing terms need verification on the correct provider site.
Read Eden review →EllieMD
Editorial source recordProduct formulation and the separate partner program deserve different questions.
Read EllieMD review →Embody
Editorial source recordA low advertised medication price still needs the shipment cutoff beside it.
Read Embody review →EverlyfeMD
Editorial source recordEverlyfeMD: the older EverlyfeMD record needs a current program-specific source. Everlywell’s broader public catalog does not establish every earlier price, medication or membership statement.
Read EverlyfeMD review →Fella Health
Editorial source recordFella Health: fella’s checked public site presents weight-management and other men’s-health pathways. Their terms should be separated rather than treating the broader catalog as one medication plan.
Read Fella Health review →Found
Editorial source recordFound offers insurance and cash-pay pathways; membership, medication and prepaid promotions must stay attached to the selected route.
Read Found review →Fridays
Editorial source recordMultiple promotion blocks make the selected term more useful than a single headline.
Read Fridays review →FuturHealth
Editorial source recordFuturHealth’s current public destination describes weight-care medication, telehealth dietitians and diet planning. The individual prescription and payment must be established through the selected program.
Read FuturHealth review →Get Thin MD
Editorial source recordGet Thin MD: the current Get Thin destination presents several treatment categories and starting-price language. A quote needs the selected product, payment term and inclusions; the general menu cannot supply them.
Read Get Thin MD review →GoodRx
Editorial source recordGoodRx: a current selected GLP-1 offer has not been established for this directory record. Confirm the provider’s present service scope, prescription process and complete payment before treating older descriptions as current.
Read GoodRx review →Henry Meds
Editorial source recordHenry’s broad treatment catalog makes the selected program, delivery timing and cancellation route the key comparison details.
Read Henry Meds review →Hers
Editorial source recordHers: a current selected GLP-1 offer has not been established for this directory record. Confirm the provider’s present service scope, prescription process and complete payment before treating older descriptions as current.
Read Hers review →HeyDoctor
Editorial source recordHeyDoctor: the older HeyDoctor name needs to be reconciled with the current care service and its published scope. This page does not treat a legacy name as proof of a currently purchasable GLP-1 program.
Read HeyDoctor review →Hims
Editorial source recordHims: a current selected GLP-1 offer has not been established for this directory record. Confirm the provider’s present service scope, prescription process and complete payment before treating older descriptions as current.
Read Hims review →Ivím Health
Editorial source recordThe semaglutide offer and membership are two different charges.
Read Ivím Health review →Juniper
Editorial source recordJuniper services and availability depend on the country and selected local program. This directory does not establish a US prescription offer from a brand name alone.
Read Juniper review →K Health
Editorial source recordK Health’s checked homepage emphasizes clinical infrastructure for health systems. It does not establish the older directory’s assumed direct-to-consumer GLP-1 package.
Read K Health review →Klarity Health
Editorial source recordKlarity’s provider marketplace requires a visit-plus-pharmacy comparison.
Read Klarity Health review →Lemonaid Health
Editorial source recordLemonaid Health: lemonaid’s current menu includes weight-care and other services. A product-specific review needs the named preparation, prescribing route and selected terms rather than an assumed universal telehealth fee.
Read Lemonaid Health review →LifeMD
Editorial source recordLifeMD’s weight-care offers sit beside primary-care memberships; the selected medication pathway determines the real invoice.
Read LifeMD review →MEDVi
Editorial source recordKeep the dated FDA letter distinct from a claim about today’s service.
Read MEDVi review →Mochi Health
Editorial source recordMochi’s broader care catalog separates medication entry prices from membership and promotional first-month language.
Read Mochi Health review →Noom Med
Editorial source recordNoom Med: a current selected GLP-1 offer has not been established for this directory record. Confirm the provider’s present service scope, prescription process and complete payment before treating older descriptions as current.
Read Noom Med review →Nurx
Editorial source recordNurx: a current selected GLP-1 offer has not been established for this directory record. Confirm the provider’s present service scope, prescription process and complete payment before treating older descriptions as current.
Read Nurx review →oralmeds.com / Elevate Health
Editorial source recordAn Elevate Health-branded intake and checkout offering compounded programs; the domain name does not establish an oral medication.
Read oralmeds.com / Elevate Health review →Orderly Meds
Editorial source recordOrderly Meds: a current selected GLP-1 offer has not been established for this directory record. Confirm the provider’s present service scope, prescription process and complete payment before treating older descriptions as current.
Read Orderly Meds review →Peak Wellness
Editorial source recordThe first month and the recurring price need separate lines.
Read Peak Wellness review →PlexusDx
Editorial source recordA genetics add-on and a prescription program need separate evidence and separate costs.
Read PlexusDx review →PlushCare
Editorial source recordPlushCare separates membership, visits and medication; a weight-care budget needs all three lines.
Read PlushCare review →Push Health
Editorial source recordPush Health describes tools connecting patients, medical professionals and pharmacies. An individual professional’s assessment and fees should not be treated as one platform-wide GLP-1 quote.
Read Push Health review →QuickMD
Editorial source recordQuickMD lists several care categories; a general visit price must not be mistaken for a weight-management medication package.
Read QuickMD review →Remedy Meds
Editorial source recordRemedyMeds advertises month-to-month GLP-1 care; its guarantee and outcome claims need their own evidence and terms.
Read Remedy Meds review →Ro
Editorial source recordRo Body separates the membership from medication; the first-month price is only one part of the budget.
Read Ro review →Sequence
Editorial source recordSequence: the Sequence name should be read in the context of the current WeightWatchers Clinic service. The old sequence.com destination is not a reliable basis for an up-to-date clinical or price claim.
Read Sequence review →Sesame
Editorial source recordSesame’s checked site presents a marketplace of care pathways. Pricing and scope need to follow the specific appointment or program, not an unrelated service appearing in the same catalog.
Read Sesame review →Shed (ShedRx)
Editorial source recordShed (ShedRx): a current selected GLP-1 offer has not been established for this directory record. Confirm the provider’s present service scope, prescription process and complete payment before treating older descriptions as current.
Read Shed (ShedRx) review →Sprout Health
Editorial source recordAnnual billing and renewals matter more than the daily-price slogan.
Read Sprout Health review →Teladoc Health
Editorial source recordTeladoc’s service and benefit pathways vary; identify the actual weight-care program before comparing a price.
Read Teladoc Health review →Thirty Madison
Editorial source recordThirty Madison: a current selected GLP-1 offer has not been established for this directory record. Confirm the provider’s present service scope, prescription process and complete payment before treating older descriptions as current.
Read Thirty Madison review →TrimRx
Editorial source recordTrimRx: the current treatment page did not expose enough information to verify a complete offer.
Read TrimRx review →WeightWatchers Clinic
Editorial source recordWeightWatchers Clinic: this record concerns the Clinic pathway. WeightWatchers’ general membership and clinical services should be identified separately before comparing medicine, care fees and coverage.
Read WeightWatchers Clinic review →Willow
Editorial source recordWillow’s oral catalog should be checked separately from its injectable offers.
Read Willow review →Wisp
Editorial source recordWisp’s current public site emphasizes sexual, reproductive and women’s-health care. That does not establish the older directory’s assumed dedicated GLP-1 medication program.
Read Wisp review →Yucca Health
Editorial source recordA six-month offer and a conditional guarantee need to be read as a single agreement.
Read Yucca Health review →Zealthy
Editorial source recordAn insured copay illustration and a cash-pay offer cannot be compared as equivalent prices.
Read Zealthy review →Zeus Health
Editorial source recordZeus Health: the available public evidence did not establish a current consumer GLP-1 program for this record. The earlier directory’s medication and pricing assumptions are not presented as verified offers.
Read Zeus Health review →